Claris Law Legal Blogging Community

Recent Entries

RSS 2.0 feed Add to My Yahoo!
Add to Bloglines Add to your My Feedster
Add to your NewsGator My MSN
Trasylol Lawyer

Risks Even with Established Drugs

editor photo

Editor: Jamie Sheller
Profession: Trasylol Attorney

January 23, 2008

By Paul Napoli

TrackBack (0)

Category: Trasylol Discussion

Even after a prescription drug has been on the market for many years there is no guarantee that they are safe. Recent drugs to go under the microscope are Vytorin, Trasylol, and Avandia. Vytorin is a cholesterol lowering drugs which studies say does not decrease the risk of heart attacks and strokes.

Vytorin isn't the only medication to come under a microscope years after it was approved. In November, Bayer Health Care voluntarily yanked from the market a drug called Trasylol, designed to prevent blood loss and the need for transfusions, after a Canadian analysis demonstrated that it increased the risk of death.

Last summer, studies revealed heart failure risks associated with two diabetes drugs, Avandia and Actos. Now, both drugs' labels carry a black box warning, the U.S. Food and Drug Administration's highest level of caution.

Watchdog groups say the push to get drugs on the market faster can be deadly to patients. They are calling for more safeguards and higher standards in the system.

Trackback Pings

TrackBack URL for this entry:
http://myblog.clarislaw.com/cgi-bin/usa/mt-tb.cgi/2130

Email Article



(optional):